Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer.

MLA

Mukai, Hirofumi, et al. “Anthracycline-Containing Regimens or Taxane versus S-1 as First-Line Chemotherapy for Metastatic Breast Cancer.” British Journal of Cancer, vol. 125, no. 9, Oct. 2021, pp. 1217–25. EBSCOhost, https://doi.org/10.1038/s41416-021-01531-6.

APA

Mukai, H., Uemura, Y., Akabane, H., Watanabe, T., Park, Y., Takahashi, M., Sagara, Y., Nishimura, R., Takashima, T., Fujisawa, T., Hozumi, Y., & Kawahara, T. (2021). Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer. British Journal of Cancer, 125(9), 1217–1225. https://doi.org/10.1038/s41416-021-01531-6

Chicago

Mukai, Hirofumi, Yukari Uemura, Hiromitsu Akabane, Takanori Watanabe, Youngjin Park, Masato Takahashi, Yoshiaki Sagara, et al. 2021. “Anthracycline-Containing Regimens or Taxane versus S-1 as First-Line Chemotherapy for Metastatic Breast Cancer.” British Journal of Cancer 125 (9): 1217–25. doi:10.1038/s41416-021-01531-6.